Concepedia

Publication | Open Access

Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab?

DOIFull Paper Access

26

Citations

33

References

2014

Year

Ahmet Dirican, Umut Varol, Yüksel Küçükzeybek, Ahmet Alacacıoğlu, Çiğdem Erten, Alper Can, Lütfiye Demir, İbrahim Vedat Bayoğlu, Murat Akyol, Betül Koyuncu,
Asian Pacific Journal of Cancer Prevention

Abstract

We conclude that NLR, a basal cancer related inflammation marker, is associated with the resistance to bevacizumab- based treatments in mCRC patients.

References

YearCitations

Page 1